A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Source:http://linkedlifedata.com/resource/pubmed/id/12200353

Blood 2002 Sep 15 100 6 1965-71

Download in:

View as

Triples

General Info

PMID
12200353